Emerging drugs for the treatment of Waldenström macroglobulinemia.
Despina FotiouMeletios- Athanasios DimopoulosEfstathios KastritisPublished in: Expert opinion on emerging drugs (2020)
The optimal therapeutic approach for WM patients is not currently established. The question of whether a combinatory (or synergistic) regimen to overcome resistance and allow for fixed- duration treatment will allow for deep/durable responses is being addressed in ongoing clinical trials.